Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиAurinia Pharmaceuticals Мультипликаторы 2011-2024 | AUPH
Мультипликаторы по годам Aurinia Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-32.5 | -49.6 | -8.8 | -16.2 | -13.2 | -8.4 | -6.0 | -4.8 | -3.5 | -5.9 | - | - | - |
P/S |
19.4 | 45.4 | 34.9 | 33.1 | 5136.8 | 1164.6 | 1009.5 | 652.7 | 273.7 | 351.4 | - | - | - |
EPS |
-0.2 | -0.2 | -1.4 | -0.9 | -0.9 | -0.6 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
995 млн | 1.26 млрд | 1.42 млрд | 1.44 млрд | 1.38 млрд | 455 млн | 448 млн | 134 млн | 77.9 млн | 105 млн | 9.84 млн | 6.28 млн | 7.91 млн |
EBITDA per Share |
-0.13 | -0.18 | -1.38 | -0.87 | -0.803 | -0.644 | -0.593 | -0.605 | -0.685 | -0.541 | - | - | - |
EV/EBITDA |
-7.7 | -17.7 | -17.8 | -7.7 | -5.7 | -3.4 | -2.7 | -4.8 | - | - | - | ||
PEG |
7.05 | -18.56 | -0.45 | -2.88 | 0.18 | -0.48 | 0.15 | 0.35 | 1.97 | 0.14 | - | - | - |
P/B |
2.3 | 3.2 | 3.3 | 4.1 | 6.0 | 4.8 | 2.6 | 3.1 | 3.2 | 2.9 | - | - | - |
P/CF |
-26.1 | -16.2 | -10.1 | -23.7 | -25.7 | -10.4 | -10.3 | -6.0 | -3.6 | -5.7 | - | - | - |
ROE % |
-7.11 | -6.42 | -37.77 | -25.18 | -45.28 | -56.96 | -42.71 | -64.80 | -93.21 | -49.15 | - | - | - |
ROA % |
-4.90 | -5.53 | -33.30 | -22.15 | -37.91 | -43.96 | -37.29 | -40.87 | -55.43 | -31.78 | - | - | - |
ROCE % |
-7.85 | -6.93 | -37.72 | -25.58 | -24.18 | -40.52 | -25.90 | -46.50 | -78.73 | -34.88 | - | - | - |
Current Ratio |
3.2 | 7.2 | 8.5 | 8.3 | 27.9 | 18.3 | 21.5 | 5.2 | 4.6 | 11.8 | - | - | - |
DSO |
152.1 | 185.5 | 65.8 | 3.7 | 422.4 | 171.1 | 94.7 | 181.4 | 73.0 | 120.8 | - | - | - |
DIO |
831.5 | 1420.2 | 5562.5 | - | - | - | - | - | - | - | - | - | - |
DPO |
95.6 | 224.5 | 1089.6 | - | 28.7 | 26.0 | 40.6 | 71.9 | 47.4 | 55.5 | - | - | - |
Операционный цикл |
983.5 | 1605.7 | 5628.2 | 3.7 | 422.4 | 171.1 | 94.7 | 181.4 | 73.0 | 120.8 | - | - | - |
Финансовый цикл |
887.9 | 1381.2 | 4538.6 | 3.7 | 393.7 | 145.0 | 54.1 | 109.6 | 25.6 | 65.3 | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Aurinia Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.07 | - | -0.09 | -0.08 | -0.18 | - | -0.06 | -0.25 | -0.27 | -0.25 | -0.39 | -0.37 | -0.4 | -0.06 | -0.34 | -0.24 | -0.23 | -0.36 | -0.25 | -0.18 | -0.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.06 | - | -0.11 | -0.11 | -0.2 | - | -0.06 | -0.25 | -0.26 | -0.23 | -0.38 | -0.37 | -0.39 | -0.06 | -0.35 | -0.24 | -0.24 | -0.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-12.78 | -13.07 | -15.20 | -13.89 | -19.34 | -18.90 | -25.86 | -40.59 | -46.36 | -51.57 | -46.59 | -40.07 | -32.43 | -25.18 | -34.74 | -24.41 | -17.90 | -11.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-9.02 | -10.32 | -12.16 | -11.58 | -16.91 | -16.69 | -22.82 | -27.51 | -39.68 | -44.34 | -39.95 | -35.08 | -28.63 | -22.15 | -31.03 | -21.94 | -16.22 | -10.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-16.11 | -15.85 | -18.09 | -16.19 | -20.56 | -19.19 | -26.02 | -40.66 | -46.35 | -51.55 | -46.70 | -40.19 | -32.59 | -25.58 | -35.27 | -24.89 | -18.30 | -11.67 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.3 | 3.2 | 3.4 | 3.5 | 7.4 | 7.2 | 7.5 | - | 8.6 | 8.4 | 5.8 | 7.2 | 8.9 | 8.3 | 8.3 | 8.3 | 8.3 | 12.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
48.1 | - | 48.1 | 42.4 | 43.1 | - | 34.2 | 33.0 | 75.6 | 49.2 | 44.3 | 38.6 | 59.2 | - | - | - | 559.7 | 579.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
467.7 | - | 444.7 | 1894.5 | 6122.7 | - | 472.1 | 749.5 | 8125.5 | - | 6586.7 | 4934.6 | 28385.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
58.9 | - | 92.1 | 247.8 | 733.4 | - | - | 93.2 | 1273.6 | - | 1041.5 | 698.7 | 4578.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
515.8 | - | 492.8 | 1936.8 | 6165.9 | - | 506.3 | 782.5 | 8201.1 | 49.2 | 6631.0 | 4973.2 | 28444.7 | - | - | - | 559.7 | 579.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
456.9 | - | 400.7 | 1689.1 | 5432.5 | - | 506.3 | 689.3 | 6927.5 | 49.2 | 5589.5 | 4274.5 | 23866.0 | - | - | - | 559.7 | 579.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD